Beam Therapeuticsの内部者の所有権
Beam Therapeuticsの内部者の所有権は何ですか。
Beam Therapeutics Inc.の内部者の所有権は1.90%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
NASDAQのセクタHealth Careにおける内部者の所有権の企業と比べるBeam Therapeutics
Beam Therapeuticsは何をしますか。
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Beam Therapeuticsと類似の内部者の所有権
- Five Below Incの内部者の所有権は1.89%です。
- Charter Hall Retail Real Estate Investment Trustの内部者の所有権は1.89%です。
- Coherent Corpの内部者の所有権は1.89%です。
- Oxford Immunotec Global PLCの内部者の所有権は1.89%です。
- Silver Lake Resourcesの内部者の所有権は1.90%です。
- CryoPort Incの内部者の所有権は1.90%です。
- Beam Therapeuticsの内部者の所有権は1.90%です。
- Murata Manufacturing Coの内部者の所有権は1.90%です。
- Vista Outdoor Incの内部者の所有権は1.90%です。
- Timbercreekの内部者の所有権は1.90%です。
- iRobotの内部者の所有権は1.90%です。
- Cincinnatiの内部者の所有権は1.90%です。
- AMBACの内部者の所有権は1.91%です。